Revised SPC: Tybost (cobicistat) 150mg film coated tablet

The licensed indication has been extended to include adolescents aged 12 years and older, weighing at least 35 kg when co-administered with atazanavir or weighing at least 40 kg when co-administered with darunavir, for the treatment of HIV-1.

electronic Medicines compendium